Holds 5 patents (2 issued; 3 provisional) in ionizable lipids and LNP manufacturing. Leads the Mason-AexeRNA public-private partnership and is principal investigator on $1.7M+ awards to scale and characterize mRNA–LNP vaccines. Works across chemistry, materials, and bioengineering.